Remote Jobs at Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc.

201 - 500 employees

🧬 Biotechnology

💊 Pharmaceuticals

🔬 Science

💰 $300M Post-IPO Equity - Xenon Pharmaceuticals on 2023-11

Biotechnology • Pharmaceuticals • Science

Xenon Pharmaceuticals Inc. is a clinical-stage biotechnology company focused on neuroscience drug discovery and development. It leverages human genetics, ion-channel biology, and novel chemistries to create selective modulators of central and peripheral nervous system ion channels. Its lead late-stage investigational candidate, azetukalner, is being developed for epilepsy and depression. The company emphasizes patient-centered research, clinical trials, and support for people affected by neurological and psychiatric disorders.